<VariationArchive RecordType="classified" VariationID="528327" VariationName="NC_000016.10:g.(?_88856738)_(88856897_?)del" VariationType="Deletion" Accession="VCV000528327" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2018-10-10" MostRecentSubmission="2018-10-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="529284" VariationID="528327">
      <GeneList>
        <Gene Symbol="GALNS" FullName="galactosamine (N-acetyl)-6-sulfatase" GeneID="2588" HGNC_ID="HGNC:4122" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88813734" stop="88856947" display_start="88813734" display_stop="88856947" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88880141" stop="88923373" display_start="88880141" display_stop="88923373" Strand="-" />
          </Location>
          <OMIM>612222</OMIM>
        </Gene>
        <Gene Symbol="LOC130059762" FullName="ATAC-STARR-seq lymphoblastoid silent region 7883" GeneID="130059762" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88856680" stop="88857079" display_start="88856680" display_stop="88857079" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="TRAPPC2L" FullName="trafficking protein particle complex subunit 2L" GeneID="51693" HGNC_ID="HGNC:30887" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88856220" stop="88862678" display_start="88856220" display_stop="88862678" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88923505" stop="88927519" display_start="88923505" display_stop="88927519" Strand="+" />
          </Location>
          <OMIM>610970</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000016.10:g.(?_88856738)_(88856897_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" innerStart="88856738" innerStop="88856897" display_start="88856738" display_stop="88856897" variantLength="160" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" innerStart="88923146" innerStop="88923305" display_start="88923146" display_stop="88923305" variantLength="160" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.(?_88856738)_(88856897_?)del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.(?_88856738)_(88856897_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.(?_88923146)_(88923305_?)del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.(?_88923146)_(88923305_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000016.10:g.(?_88856738)_(88856897_?)del AND Mucopolysaccharidosis, MPS-IV-A" Accession="RCV000633469" Version="2">
        <ClassifiedConditionList TraitSetID="175">
          <ClassifiedCondition DB="MedGen" ID="C0086651">Mucopolysaccharidosis, MPS-IV-A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-05-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-05-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2018-10-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="175" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3036" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MPS IVA</ElementValue>
                <XRef Type="MIM" ID="253000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio syndrome A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis Type IVA</ElementValue>
                <XRef ID="NBK148668" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio syndrome A, mild</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-IV-A</ElementValue>
                <XRef ID="Morquio+syndrome+A/4876" DB="Genetic Alliance" />
                <XRef ID="7259005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 4A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio A disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactosamine-6-sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type IV A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS4A</ElementValue>
                <XRef Type="MIM" ID="253000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3785" />
                <XRef ID="3785" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of mucopolysaccharidosis IVA (MPS IVA) is a continuum that ranges from a severe and rapidly progressive early-onset form to a slowly progressive later-onset form. Children with MPS IVA typically have no distinctive clinical findings at birth. The severe form is usually apparent between ages one and three years, often first manifesting as kyphoscoliosis, genu valgum (knock-knee), and pectus carinatum; the slowly progressive form may not become evident until late childhood or adolescence, often first manifesting as hip problems (pain, stiffness, and Legg Perthes disease). Progressive bone and joint involvement leads to short stature, and eventually to disabling pain and arthritis. Involvement of other organ systems can lead to significant morbidity, including respiratory compromise, obstructive sleep apnea, valvular heart disease, hearing impairment, visual impairment from corneal clouding, dental abnormalities, and hepatomegaly. Compression of the spinal cord is a common complication that results in neurologic impairment. Children with MPS IVA have normal intellectual abilities at the outset of the disease.</Attribute>
                <XRef ID="NBK148668" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23844448</ID>
                <ID Source="BookShelf">NBK148668</ID>
              </Citation>
              <XRef ID="309297" DB="Orphanet" />
              <XRef ID="582" DB="Orphanet" />
              <XRef ID="C0086651" DB="MedGen" />
              <XRef ID="MONDO:0009659" DB="MONDO" />
              <XRef Type="MIM" ID="253000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1464148" SubmissionDate="2018-08-29" DateLastUpdated="2018-10-10" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2891683|MedGen:C0086651" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000754698" DateUpdated="2018-10-10" DateCreated="2018-05-28" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon 1 of the GALNS gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the GALNS gene. This is expected to result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with GALNS-related disease. Loss-of-function variants in GALNS are known to be pathogenic (PMID: 12442278). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.(?_88923146)_(88923305_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-IV-A</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0086651" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1464148" TraitType="Disease" MappingType="Name" MappingValue="Mucopolysaccharidosis, MPS-IV-A" MappingRef="Preferred">
        <MedGen CUI="C0086651" Name="Mucopolysaccharidosis, MPS-IV-A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

